Jubilant Pharmova Singapore to sell its entire 25.8% stake in Sofie Biosciences, USA
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
The company intends to respond to the two minor observations within the stipulated time
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)
Inducts advanced AI-Powered 24x7 remote patient monitoring system
A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Subscribe To Our Newsletter & Stay Updated